Evidence map›Paper›PMID 40506843›Full record

ArticleBrain pathology (Zurich, Switzerland)2025

Human amyotrophic lateral sclerosis/motor neuron disease: The disease-associated microglial pathway is upregulated while APOE genotype governs risk and survival.

Bridget A Ashford, Julie E Simpson, Charlotte Dawson, Delphine Boche, Johnathan Cooper-Knock, Paul R Heath, Daniel Fillingham, Charlie Appleby-Mallinder, Wenbin Wei, Mark Dunning and 1 more

Abstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bridget A AshfordSITraN, University of Sheffield, Sheffield, UK.
Julie E SimpsonSITraN, University of Sheffield, Sheffield, UK.
Charlotte DawsonSITraN, University of Sheffield, Sheffield, UK.
Delphine BocheClinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.ORCID 0000-0002-5884-130X
Johnathan Cooper-KnockSITraN, University of Sheffield, Sheffield, UK.ORCID 0000-0002-0873-8689
Paul R HeathSITraN, University of Sheffield, Sheffield, UK.
Daniel FillinghamSITraN, University of Sheffield, Sheffield, UK.
Charlie Appleby-MallinderAdvanced Manufacturing Research Centre, University of Sheffield, Rotherham, UK.
Wenbin WeiDepartment of Biosciences, University of Durham, Durham, UK.
Mark DunningBioinformatics Core, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
J Robin HighleySITraN, University of Sheffield, Sheffield, UK.ORCID 0000-0002-4969-6526

Funding

British Neuropathological SocietyBruker Spatial BiologyPathological Society of Great Britain and Ireland
6 · The paper itself

Abstract

A key role for inflammation in amyotrophic lateral sclerosis/motor neuron disease (ALS/MND) has been identified. It is vital to assess which central nervous system structures are most affected and which inflammatory processes are responsible in humans. The inflammatory transcriptome was characterized in the cervical spinal cord and motor cortex in post-mortem frozen and formalin-fixed paraffin-embedded specimens from human sporadic ALS/MND and control cases using the nCounter® Neuroinflammation Panel. Archival data were reanalyzed and compared with the nCounter data. Immunohistochemistry was used to examine the inflammatory response in the spinal cord and motor cortex and validate changes found during transcriptomic analyses. In the spinal cord, marked inflammation was observed, while less inflammation was detected in the motor cortex. Examination of differentially expressed genes in the spinal cord highlighted TREM2, TYROBP, APOE, and CD163, as well as phagocytic pathways. In sporadic ALS/MND spinal cord, significant microglial reactivity and involvement of TREM2, ApoE (encoded by APOE), and TYROBP were confirmed, suggesting the involvement of the disease-associated microglial (DAM) phenotype. The corticospinal tracts showed greater inflammation than the ventral horns. The precentral gyrus of ALS/MND again showed less immune reactivity to disease when compared to controls. Finally, in the largest cohort assessed to date, we demonstrate an association between the APOE variant and ALS/MND risk, age of onset, and survival. We find confirmed associations between APOE ε3/ε3 and disease and between ε2/ε2 and absence of disease. Further, ε4/ε4 appears to be associated with earlier disease onset and a more aggressive course. We conclude that while there is widespread inflammation in the CNS in sporadic ALS/MND, this is more marked in the spinal cord, especially the corticospinal tract. The specific markers stress the DAM phenotype as having a key role together with a possible influx of somatic macrophages. In addition, APOE function and genotype may be relevant in ALS/MND.

Indexed as

Amyotrophic Lateral SclerosisApolipoproteins EMotor CortexSpinal Cord Ventral HornAdaptor Proteins, Signal TransducingAgedBiomarkersFemaleHumansMacrophagesMaleMembrane GlycoproteinsMembrane ProteinsMicrogliaNeuroinflammatory DiseasesReceptors, ImmunologicAdaptor Proteins, Signal TransducingApolipoproteins EBiomarkersMembrane GlycoproteinsMembrane ProteinsReceptors, ImmunologicTREM2 protein, humanTYROBP protein, humanamyotrophic lateral sclerosisAPOEdisease‐associated microgliainflammationmotor neuron disease

Identifiers

PMID40506843
PMCPMC12488259

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.